Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of the Safety and Preliminary Efficacy of Neuroinduced Mesenchymal Stem Cells and Exosome Therapy in Patients With Spinocerebellar Palsy
Sponsor: Biocells Medical
Summary
This clinical study aims to evaluate the safety and preliminary therapeutic potential of mesenchymal stem cell-derived therapies in patients diagnosed with spinocerebellar palsy. The investigational treatment includes neuroinduced mesenchymal stem cells and their derived exosomes administered via intravenous and intranasal infusion.
Official title: Phase I/II Randomized Controlled Study Evaluating the Safety and Preliminary Efficacy of Neuroinduced Mesenchymal Stem Cells and Exosome Therapy in Patients With Spinocerebellar Palsy
Key Details
Gender
All
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
90
Start Date
2026-06-01
Completion Date
2029-06-01
Last Updated
2026-03-12
Healthy Volunteers
No
Conditions
Interventions
Intrathecal infusion
200,000,000 neuroinduced mesenchymal stem cells administered via intravenous infusion.
Intranasal infusion
Intranasal infusion of purified exosomes derived from mesenchymal stem cells
Locations (1)
BioCells Medical
Warsaw, Poland